Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Cancer Clinic
- Genetics
- Family Medicine and Public Health
- Hematology
- Infectious Disease
- Nursing
- Oncology Cases
- Internal Medicine
Abstract
Citation: Ann Clin Case Rep. 2017;2(1):1396.DOI: 10.25107/2474-1655.1396
A Case of Bupropion-Induced Toxic Epidermal Necrolysis (TEN)
Temiz Selami Aykut, Dursun Recep, Daye Munise, Ataseven Arzu and Özer İlkay
Department of Dermatology, Meram Faculty of Medicine, Necmettin Erbakan University Konya, Turkey
*Correspondance to: Ataseven Arzu
PDF Full Text Case Report | Open Access
Abstract:
Toxic Epidermal Necrolysis (TEN), which has high mortality, is an acute mucocutaneous disease with bullous lesions in the skin, eyes and mucosae. It often develops due to medications. Bupropion is an antidepressant that blocks neural dopamine and the noradrenaline reuptake. Its slow-release form is used in smoking cessation treatments. In the literature, Bupropion-induced side effects have been reported such as urticaria angioedema, erythema multiforme, and acute generalized eczematous pustulosis. We found it appropriate to present our case of Bupropion-induced toxic epidermal necrolysis, which has not yet been presented in the literature.
Keywords:
Toxic epidermal necrolysis; Urticarial; Bupropion; Immunoglobulin
Cite the Article:
Aykut TS, Recep D, Munise D, Arzu A, İlkay Ö. A Case of Bupropion-Induced Toxic Epidermal Necrolysis (TEN). Ann Clin Case Rep. 2017; 2: 1396. ISSN: 2474-1655.
